Microbot Medical® Highlights Growth Strategy
Microbot Medical Inc MBOT
$1.25
▼ -0.40%
($-0.01)
Open
$1.27
Prev Close
$1.25
Day Range
$1.22 – $1.28
52W Range
$1.24 – $3.46
Market Cap
$83.62M
Beta
1.04
EPS (TTM)
$-0.26
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1992-03-25 |
| Shares Out. | 67,160,000 |
| Website | microbotmedical.com/ ↗ |
| Phone | 13026587581 |
| Employees | 22 |
| Revenue | $241,000 |
| Gross Profit | -$643,000 |
| Net Income | -$5.6M |
| Free Cash Flow | -$17.9M |
| Total Assets | $73.4M |
| Total Liabilities | $4.4M |
| Equity | $68.9M |
About Microbot Medical Inc
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
Microbot Medical Inc is a publicly traded company under the ticker symbol MBOT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-09-01)